Summary: Riluzole, an FDA-approved drug to treat ALS, may, in part, correct the molecular cause of some leukodystrophies. Source: Montreal university There is new hope for the future treatment of certain leukodystrophies, neurodegenerative diseases in young children that progressively affect their quality of life, often leading to death before adulthood. The development stems from the …
The researchers anticipate that the success of the study will have positive implications for clinical treatment. The treatment caused neurological changes, including a decrease in inflammation and an increase in functionality, according to the researchers. A recent study from Tel Aviv University found that pressure chamber therapy significantly improved social skills and brain status in …
With new variants and subvariants of COVID evolving faster and faster, each reducing the effectiveness of major vaccines, the hunt is on for a new type of vaccine, one that works equally well on current and future forms of the novel coronavirus. . Now researchers at the National Institutes of Health in Maryland believe they’ve …
Vaccine breakthrough could finally bring COVID to its knees Read More »
